The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Janssen Research & Development
The FDA issued an EUA for the third vaccine for the prevention of COVID-19.
read more
Regeneron announced changes to the Phase 3 trial assessing investigational REGEN-COV in outpatients with COVID-19, following recommendations from the ...
read more
Friday, February 26, 2021
Elicio has received IND clearance from the FDA for ELI-002.
read more
Friday, February 26, 2021
NeuroRx announced the trial of ZYESAMI for Respiratory Failure in critically ill patients with COVID-19 demonstrated multidimensional benefit around ...
read more
Friday, February 26, 2021
Akero has screened the first patients for its Phase 2b HARMONY study evaluating efruxifermin for NASH.
read more
Thursday, February 25, 2021
Compugen announced the expansion of its agreement with Bristol Myers Squibb.
read more
Thursday, February 25, 2021
RedHill Biopharma has announced its plans to expand the Company's global Phase 2/3 study of opaganib in patients with severe COVID-19 to the U.S.
read more
Thursday, February 25, 2021
INOVIO announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana.
read more
Wednesday, February 24, 2021
Otonomy announced the Phase 3 clinical trial of OTIVIDEX in patients with Ménière’s disease did not achieve the primary endpoint, which was the count ...
read more
Wednesday, February 24, 2021
BrainStorm recently met with senior leadership from the FDA and received feedback on a high-level data summary from the NurOwn ALS Phase 3 clinical ...
read more
Tuesday, February 23, 2021
Astellas and Seagen announced completion of submissions for two sBLAs to the FDA for PADCEV.
read more
Tuesday, February 23, 2021
Perception Neuroscience announced positive data from its first Phase 1 clinical study demonstrating the safety and tolerability of PCN-101 (R-ketamine...
read more
Monday, February 22, 2021
The FDA has issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the ...
read more
Thursday, February 18, 2021
Amgen announced the FDA has granted Priority Review for sotorasib for KRAS G12C-mutated locally advanced or metastatic NSCLC.
read more
Thursday, February 18, 2021
Verrica announced its resubmitted NDA for VP-102, a proprietary topical therapy for the treatment of molluscum contagiosum, has been accepted for ...
read more